USFDA concludes audit for Laurus Labs’ API manufacturing facility at Hyderabad with zero Form 483 observations
The USFDA inspection focused on evaluating the facility's adherence to global regulatory requirements and best practices
The USFDA inspection focused on evaluating the facility's adherence to global regulatory requirements and best practices
GPCB has also asked to submit a bank guarantee of Rs. 2, 00,000 for compliance assurance at the time of revocation and has also ordered to deposit interim environment damage compensation amount
The acquisition is based on an enterprise value of Rs. 1,660 crore
This aims to benefit approximately 4.5 crore families with six crore senior citizens with Rs. 5 lakh free health insurance cover on a family basis
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
Jubilant HollisterStier is a subsidiary of Jubilant Pharma Holding
ALS patients experience neuroinflammation and rapid neurodegeneration
This case is an isolated case, similar to the earlier 30 cases reported in India from July 2022 onwards
Agreement further expands Aptar Pharma’s leading respiratory portfolio
Ami informs that PMDA Japan has issued Inspection Result Report declaring the Sachin facility as a Good Manufacturing Practices (GMP) compliant.
Subscribe To Our Newsletter & Stay Updated